Company intelligence / Profile preview

AnalytiCon Discovery

Potsdam, Brandenburg, Germanyac-discovery.com ↗

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

AnalytiCon Discovery specializes in the rapid identification, isolation, synthesis, and optimization of natural products for use in pharmaceutical research. Their high-throughput structure elucidation technology enables fast generation of pure compounds from natural sources. They provide large ready-to-screen libraries to pharma/biotech partners but do not themselves advance clinical candidates.

Therapeutic areas: OncologyPulmonologyDermatologyRheumatology
Modalities: Small moleculeNatural product-derived small moleculeSemi-synthetic compoundMacrocyclic compound (macrocycle)Combinatorial library (as a platform for discovery)
Industry: Drug Discovery Services

Partnerships

Merck KGaABRAIN AG/BRAIN Group

Beyond the preview

Go deeper on AnalytiCon Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnalytiCon Discovery.

Explore the full profile